» Articles » PMID: 11799084

Gene Transfer of CGMP-dependent Protein Kinase I Enhances the Antihypertrophic Effects of Nitric Oxide in Cardiomyocytes

Overview
Journal Hypertension
Date 2002 Jan 19
PMID 11799084
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

NO acting through soluble guanylyl cyclase and cGMP formation is a negative regulator of cardiomyocyte hypertrophy. Downstream targets mediating the inhibitory effects of NO/cGMP on cardiomyocyte hypertrophy have not been elucidated. In addition to its antihypertrophic effects, NO promotes apoptosis in cardiomyocytes, presumably through cGMP-independent pathways. We investigated the role of cGMP-dependent protein kinase (PKG) in the antihypertrophic and proapoptotic effects of NO. Incubation of neonatal rat cardiomyocytes with the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) (250 micromol/L) or the PKG-selective cGMP analog 8-pCPT-cGMP (500 micromol/L) activated endogenous PKG type I, as shown by the site-specific phosphorylation of vasodilator-stimulated phosphoprotein, a well-characterized PKG substrate. SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) modestly attenuated the hypertrophic response to alpha(1)-adrenergic stimulation with phenylephrine. Although a high concentration of SNAP (1000 micromol/L) promoted apoptosis in cardiomyocytes, as evidenced by the formation of histone-associated DNA fragments, antihypertrophic concentrations of SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) did not promote cell death. Because chronic activation downregulated endogenous PKG I, we explored whether gene transfer of PKG I would enhance the sensitivity of cardiomyocytes to the antihypertrophic effects of NO/cGMP. Indeed, after adenoviral overexpression of PKG Ibeta, SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) completely suppressed the hypertrophic response to alpha(1)-adrenergic stimulation. As observed in noninfected cells, SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) did not promote apoptosis in cardiomyocytes overexpressing PKG Ibeta. Moreover, overexpression of PKG Ibeta did not enhance the proapoptotic effects of 1000 micromol/L SNAP, implying PKG-independent effects of NO on apoptosis. Endogenous PKG I mediates antihypertrophic but not proapoptotic effects of NO in a cell culture model of cardiomyocyte hypertrophy. Adenoviral gene transfer of PKG I selectively enhances the antihypertrophic effects of NO without increasing the susceptibility to apoptosis.

Citing Articles

The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies.

Cai Z, Wu C, Xu Y, Cai J, Zhao M, Zu L Aging Dis. 2023; 14(1):46-62.

PMID: 36818566 PMC: 9937694. DOI: 10.14336/AD.2022.0523.


Endothelial Dysfunction and Diabetic Cardiomyopathy.

Wang M, Li Y, Li S, Lv J Front Endocrinol (Lausanne). 2022; 13:851941.

PMID: 35464057 PMC: 9021409. DOI: 10.3389/fendo.2022.851941.


Understanding the Genetic and Molecular Basis of Familial Hypertrophic Cardiomyopathy and the Current Trends in Gene Therapy for Its Management.

Pradeep R, Akram A, Proute M, Kothur N, Georgiou P, Serhiyenia T Cureus. 2021; 13(8):e17548.

PMID: 34646605 PMC: 8481153. DOI: 10.7759/cureus.17548.


Endothelial Dysfunction: A Contributor to Adverse Cardiovascular Remodeling and Heart Failure Development in Type 2 Diabetes beyond Accelerated Atherogenesis.

Gamrat A, Surdacki M, Chyrchel B, Surdacki A J Clin Med. 2020; 9(7).

PMID: 32635218 PMC: 7408687. DOI: 10.3390/jcm9072090.


Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure.

Preedy M Cardiovasc Drugs Ther. 2020; 34(3):401-417.

PMID: 32172427 PMC: 7242274. DOI: 10.1007/s10557-020-06959-1.